Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Consolidated Diluted EPS At -3.0924

0

For the year ended 2015-12-31 Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) basic consolidated EPS came $-3.0924. Furthermore, for the quarter closed 2015-12-31, it was $-3.0924.

Consolidated diluted EPS

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) consolidated diluted EPS was -3.0924 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it stood at $-3.0924.

EPS contribution from parent

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) basic EPS was $-3.0924 for the year ended 2015-12-31 from its parent entity. It was $-3.0924 for the quarter closed 2015-12-31.

EPS from continuing operations

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) EPS from continuing activities was $-3.0924 for the fiscal ended 2015-12-31. For the quarter ended 2015-12-31, this figure was $-3.0924.

Basic net EPS

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) basic net EPS was $-3.09 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it came at $-3.09.

Diluted EPS from parent

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) diluted EPS from parent entity came at $-3.0924 for the year ended 2015-12-31. For the quarter ended 2015-12-31 it was $-3.0924.

Net diluted EPS

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) net diluted EPS was $-3.09 for the fiscal closed 2015-12-31. For the quarter ended 2015-12-31, net diluted EPS was $-3.09.

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) net basic EPS was $-3.09 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it was $-3.09.

Basic diluted EPS

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) basic diluted EPS was $-0.7537 for the quarter ended 2015-12-31. For the year ended 2015-12-31, basic diluted EPS was $-0.7537.

For the year ended 2015-12-31, basic shares outstanding were 20.321 while for the quarter ended 2015-12-31 is 20.321.

For the fiscal ended 2015-12-31, the diluted outstanding shares were 20.321 and for the quarter ended 2015-12-31 it was 20.321. Earnings per share and diluted EPS are profitability metrics used in fundamental analysis of firms. EPS just takes into account a firm’s common shares, while diluted EPS considers all convertible securities. Per-share earnings measure the quantum of a company’s earnings on a per share basis. Basic EPS does not consider any dilutive impact that convertible securities leave on EPS. On contrary, diluted EPS is a tool used in fundamental study to gauge a firm’s quality of EPS, assuming there is conversion of all convertible securities.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 16 times, 1 visits today)